Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.

Also called NCT05780359

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 280 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05780359
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05780359. Randomized; single masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2025-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
Acronym
G-streamPAD
Condition
Peripheral Artery Disease
Intervention (Device)
Drug eluting stent
Intervention (Device)
drug coating balloon
Lead sponsor
Shenzhen Salubris Pharmaceuticals Co., Ltd. (class: industry)
Collaborator
Changhai Hospital (class: other)

Record details

Record id
cardio:ct-nct05780359
Content hash
921672fac4abb6212d05a62374200633d645e6148183494e9554ca4cc83be2e7